151 related articles for article (PubMed ID: 7977813)
21. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart.
Wang QD; Li XS; Pernow J
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S445-7. PubMed ID: 8587441
[TBL] [Abstract][Full Text] [Related]
22. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog.
Krause SM; Lynch JJ; Stabilito II; Woltmann RF
Cardiovasc Res; 1994 Nov; 28(11):1672-8. PubMed ID: 7842461
[TBL] [Abstract][Full Text] [Related]
23. Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion.
Viehman GE; Ma XL; Lefer DJ; Lefer AM
Am J Physiol; 1991 Sep; 261(3 Pt 2):H874-81. PubMed ID: 1653539
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin.
Massoudy P; Zahler S; Kupatt C; Reder E; Becker BF; Gerlach E
J Mol Cell Cardiol; 1997 Feb; 29(2):535-44. PubMed ID: 9140813
[TBL] [Abstract][Full Text] [Related]
25. The role of endothelin in mediating ischemia/hypoxia-induced atrial natriuretic peptide release.
Zhang Y; Oliver JR; Horowitz JD
J Cardiovasc Pharmacol; 2004 Feb; 43(2):227-33. PubMed ID: 14716210
[TBL] [Abstract][Full Text] [Related]
26. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.
Zaugg CE; Hornstein PS; Zhu P; Simper D; Lüscher TF; Allegrini PR; Buser PT
Circulation; 1996 Aug; 94(4):742-7. PubMed ID: 8772697
[TBL] [Abstract][Full Text] [Related]
27. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
28. Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction.
Evora PR; Pearson PJ; Schaff HV
Ann Thorac Surg; 1994 Jun; 57(6):1550-6. PubMed ID: 8010801
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat.
Qi XL; Nguyen TL; Andries L; Sys SU; Rouleau JL
Can J Physiol Pharmacol; 1998 Jan; 76(1):35-45. PubMed ID: 9564547
[TBL] [Abstract][Full Text] [Related]
30. The ETA antagonist BQ-123 inhibits anoxic contractions of canine coronary arteries without endothelium.
Vedernikov YP; Goto K; Vanhoutte PM
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S252-6. PubMed ID: 7509958
[TBL] [Abstract][Full Text] [Related]
31. Effect of an endothelin-receptor antagonist on ischemic acute renal failure.
Chan L; Chittinandana A; Shapiro JI; Shanley PF; Schrier RW
Am J Physiol; 1994 Jan; 266(1 Pt 2):F135-8. PubMed ID: 8304480
[TBL] [Abstract][Full Text] [Related]
32. Coronary constriction and consequent cardiodepression in pulmonary embolism are mediated by pulmonary big endothelin and enhanced in early endothelial dysfunction.
Dschietzig T; Laule M; Alexiou K; Schrör K; Baumann G; Stangl K
Crit Care Med; 1998 Mar; 26(3):510-7. PubMed ID: 9504580
[TBL] [Abstract][Full Text] [Related]
33. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury.
Ozdemir R; Parlakpinar H; Polat A; Colak C; Ermis N; Acet A
Toxicology; 2006 Feb; 219(1-3):142-9. PubMed ID: 16406210
[TBL] [Abstract][Full Text] [Related]
34. Coronary vasoconstriction mediated by endothelin-1 in neonates. Reversal by nitroglycerin.
McGowan FX; Davis PJ; Siewers RD; del Nido PJ
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):88-97; discussion 97-8. PubMed ID: 7815811
[TBL] [Abstract][Full Text] [Related]
35. Additive effects of L-arginine infusion and leukocyte depletion on recovery after hypothermic ischemia in neonatal lamb hearts.
Hiramatsu T; Forbess JM; Miura T; Nomura F; Mayer JE
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):172-9. PubMed ID: 7609541
[TBL] [Abstract][Full Text] [Related]
36. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.
Beresewicz A; Czarnowska E; Maczewski M
Mol Cell Biochem; 1998 Sep; 186(1-2):87-97. PubMed ID: 9774189
[TBL] [Abstract][Full Text] [Related]
37. Augmented contractile response to endothelin and blunted endothelium-dependent relaxation in post-ischemic reperfused coronary arteries.
Saito T; Fushimi E; Abe T; Kimura Y; Takahashi K; Kudo Y; Nakagomi A; Miura M
Jpn Circ J; 1992 Jul; 56(7):657-70. PubMed ID: 1495159
[TBL] [Abstract][Full Text] [Related]
38. Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
Kim YD; Danchak RM; Heim KF; Lees DE; Myers AK
Prostaglandins; 1993 Sep; 46(3):269-76. PubMed ID: 8234834
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610.
Han H; Neubauer S; Braeker B; Ertl G
J Mol Cell Cardiol; 1995 Feb; 27(2):761-6. PubMed ID: 7776381
[TBL] [Abstract][Full Text] [Related]
40. Effects of BQ-485, a selective ETA antagonist, on endothelin-mediated vasomotion in rat coronary vascular beds.
Sakuma I; Asajima H; Fukao M; Tohse N; Tamura M; Kitabatake A
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S400-3. PubMed ID: 8587427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
